Diagnos Inc. (CVE:ADK) (OTCMKTS:DGNOF) (FRA:4D4A), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the signing of an exclusive distribution agreement with Diagnos Europe GmbH.
Cortical is an Australian based medical device technology company that has developed an industry disruptive brain function monitor independently described as "a paradigm busting technology from an Australian based device house that really gives a significant advantage in this space".
Cann Global continued to drive sales throughout the quarter resulting in cash receipts from customers of $333k up 54.6% on the prior corresponding period, but lower than the prior quarter due to shipping delays and therefore delayed payment on contracted sales.
Cann Global Limited (ASX:CGB) is pleased to confirm that the 1 for 4 renounceable entitlement offer announced on 3 July 2020 (Entitlement Offer), closed on Thursday 23 July 2020.
Cann Global Ltd (ASX:CGB) today confirms that its Directors and largest shareholders intend to participate in the rights issues announced on 3 July 2020.
Cann Global Limited's (ASX:CGB) medical Cannabis research division, Medical Cannabis Research Group Pty Ltd (MCRG) entered into a research agreement to research the possibility of the use of cannabis in the treatment of autoimmune disease, specifically multiple sclerosis (MS).
The Board of Cann Global Limited (ASX:CGB) wishes to update our shareholders on the operations of its 55% owned subsidiary Cann Global Asia Pty Ltd, and its activities in Laos PDR.
Allwellness Holdings Group Ltd (NSX:AWH) is pleased to announce that the company and Bee Blockchain Foundation Pty Ltd (BBF) have reached a significant cooperation agreement, the major shareholders of BBF have invested in the shares of AWH and have the intention of further increase in their holdings.
On 30 April 2020, Cann Global Ltd (ASX:CGB) lodged the Company's quarterly activities and cashflow reports for the period ended 31 March 2020. This amendment includes an updated cashflow report.
In October 2019, Austrade published a report on Australia's food innovators which Cann Global Limited (ASX:CGB), through its subsidiaries T12 and HHC, is very excited to be a part of.
